A Phase I Trial of Combined Ridaforolimus and MK-2206 in Patients With Advanced Malignancies
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-15-0180
Full Text
Open PDFAbstract
Available in full text
Date
July 17, 2015
Authors
Publisher
American Association for Cancer Research (AACR)